Active RFAs at NIH (December 7, 2017)

Doc NumLinkTitleActivity CodesSponsorExpiration Date
RFA-DA-18-019LinkNIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional)DP1NIDA08-15-2020
RFA-DK-17-011LinkCatalyst Award in Diabetes, Endocrinology and Metabolic Diseases (DP1- Clinical Trial Not Allowed)DP1NIDDK02-03-2018
RFA-DA-18-004LinkAvenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2)DP2NIDA11-14-2019
RFA-MH-18-510LinkBRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)F32NIMH04-08-2020
RFA-NS-18-007LinkNIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00)F99/K00NINDS12-14-2017
RFA-HL-18-006LinkNHLBI Research Career Development Program in HIV-Related Heart, Lung, Blood and Sleep Research (K12)K12NHLBI12-15-2017
RFA-RM-17-010LinkLimited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC):  Technologies to Understand the Control of Organ Function by the Peripheral Nervous System (OT2)OT2Roadmap03-29-2019
RFA-RM-15-018LinkLimited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Comprehensive Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT2)OT2Roadmap06-15-2018
RFA-NS-18-002LinkNINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)P50NINDS12-16-2017
RFA-HL-19-011LinkShedding light on the dark genome: Long Non-coding RNA in Cardiovascular, Lung, Blood, and Sleep Research (R01 - Clinical Trial Not Allowed)R01NHLBI03-31-2018
RFA-HL-18-004LinkIntegrated Approaches to HIV-Related Heart, Lung, Blood, and Sleep (HLBS) Comorbidities (R01)R01NHLBI12-16-2017
RFA-AG-18-023LinkPathogenesis of Age-Related HIV Neurodegeneration (R01 Clinical Trial Not Allowed)R01NIA02-10-2018
RFA-AG-18-020LinkRole of Peripheral Proteostasis on Brain Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed)R01NIA02-10-2018
RFA-AG-18-021LinkSystems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) R01NIA02-22-2018
RFA-EB-17-005LinkBRAIN Initiative:  Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)R01NIBIB10-18-2019
RFA-EB-17-003LinkBRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trials Not Allowed)R01NIBIB12-12-2018
RFA-HD-18-036LinkOpioid Use Disorder in Pregnancy (R01)R01NICHD12-14-2017
RFA-DA-18-002LinkAdvancing Exceptional Research on HIV/AIDS and Substance Abuse (R01)R01NIDA08-23-2019
RFA-DA-18-018LinkBRAIN Initiative: Tools to target, identify and characterize non-neuronal cells in the brain (R01 Clinical Trial Not Allowed)R01NIDA10-05-2018
RFA-DA-18-014LinkPharmacogenomics of Anti-retroviral Therapy in People Who Inject Drugs (R01)R01NIDA12-15-2017
RFA-DA-18-015LinkHIV-associated neuropathic pain and opioid interaction (R01)R01NIDA12-19-2017
RFA-ES-17-009LinkPopulation-Based Model Organism Research for G x E Exploration in Complex Disease Outcomes (R01 Clinical Trial Not Allowed)R01NIEHS02-02-2018
RFA-MH-18-610LinkAltered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R01)-Clinical Trial Not AllowedR01NIMH01-09-2018
RFA-MH-18-200LinkNIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01)R01NIMH06-21-2019
RFA-MH-18-707LinkConfirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01- Clinical Trial Required)R01NIMH10-16-2018
RFA-MH-18-701LinkClinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01- Clinical Trial Required)R01NIMH10-16-2018
RFA-MH-18-700LinkClinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01-Clinical Trial Required)R01NIMH10-16-2018
RFA-MH-18-505LinkBRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01)R01NIMH11-14-2018
RFA-NS-18-009LinkBRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 - Clinical Trial Not Allowed)R01NINDS03-16-2018
RFA-NS-18-004LinkHuman Studies of Target Identification, Biomarkers and Disease Mechanisms Specific to CNS Small Blood and Lymphatic Vessels (R01)R01NINDS12-12-2017
RFA-NS-18-003LinkInnovative Approaches or Technologies to Investigate Regional, Structural and Functional Heterogeneity of CNS Small Blood and Lymphatic Vessels (R01) R01NINDS12-12-2017
RFA-HL-17-015LinkBold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)R21NHLBI09-08-2018
RFA-MH-18-611LinkAltered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R21- Clinical Trial Not Allowed)R21NIMH01-09-2018
RFA-AT-18-002LinkBehavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33)R21/R33NCCIH01-19-2018
RFA-MH-18-600LinkNIH Blue Print: Development and Validation of Technologies for Rapid Isolation and Characterization of Extracellular Vesicles of Central Nervous System Origin (R21/R33 Clinical Trial Not Allowed)R21/R33NIMH01-23-2018
RFA-NS-16-013LinkInnovation Grants to Nurture Initial Translational Efforts (IGNITE):  Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate the Discovery of Neurotherapeutics (R21/R33)R21/R33NINDS05-08-2018
RFA-AG-18-024LinkCollaboratory on Research Definitions for Cognitive Reserve and Resilience to Alzheimer's Disease (R24 - Clinical Trial Not Allowed)R24NIA02-23-2018
RFA-NS-18-006LinkHigh Impact Neuroscience Research Resource Grants (R24)R24NINDS02-10-2018
RFA-MH-18-705LinkDevelopment of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33- Clinical Trial Required)R33NIMH10-16-2018
RFA-MH-18-703LinkEarly Stage Testing of Pharmacologic or Device -based Interventions for the Treatment of Mental Health Disorders (R33- Clinical Trial Required)R33NIMH10-16-2018
RFA-MH-18-706LinkPilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required)R34NIMH10-16-2018
RFA-NS-18-017LinkPlanning Grant to Develop Phase III Clinical Trials for Lewy Body Dementia (R34 clinical Trial Not Allowed)R34NINDS03-21-2018
RFA-ES-17-008LinkOrganotypic Culture Models developed from Experimental Animals for Chemical Toxicity Screening (R43)R43/R44NIEHS01-13-2018
RFA-DA-18-016LinkExploiting HIV and/or Host Genomic Information to Understand HIV Compartments or Reactivation in Individuals with Substance Use Disorders (R61/R33)R61/R33NIDA12-14-2017
RFA-MH-18-704LinkDevelopment of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33- Clinical Trial Required)R61/R33NIMH10-16-2018
RFA-MH-18-702LinkEarly Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required)R61/R33NIMH10-16-2018
RFA-AG-18-018LinkDevelopment of Valid Reliable Markers of Aging-Related Biologic Mechanisms for Human Studies (U01)U01NIA01-31-2018
RFA-AG-18-013LinkContinuation of the AMP-AD Target Discovery and Preclinical Validation Consortium  (U01 Clinical Trial Optional)U01NIA02-21-2018
RFA-AG-18-019LinkEnhancing Central Neural Control of Mobility in Aging (U01 Clinical Trial Optional) U01NIA02-22-2018
RFA-EB-17-004LinkBRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01) (Clinical Trials Not Allowed)U01NIBIB12-12-2018
RFA-NS-18-010LinkBRAIN Initiative:  Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01)U01NINDS01-20-2018
RFA-NS-18-008LinkBRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01)U01NINDS12-16-2017
RFA-EY-17-003LinkNEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trials Not Allowed)U24NEI02-22-2018
RFA-AG-18-014LinkLimited Competition: Data Coordinating Center for the Accelerating Medicines Partnership Target Discovery and Preclinical Validation Consortium AMP-AD DCC (U24 Clinical Trial Not Allowed)U24NIA02-21-2018
RFA-NS-18-005LinkBRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24)U24NINDS02-10-2018
RFA-NS-18-012LinkTranslational Neural Devices (U44 - Clinical Trial Required)U44NINDS10-22-2020
RFA-NS-18-001LinkCenters Without Walls for Collaborative Research in the Epilepsies: Functional Evaluation of Human Genetic Variants (U54)U54NINDS01-17-2018
RFA-DA-18-020LinkNIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3, Clinical Trial Optional)UG3/UH3NIDA09-08-2020
RFA-NS-18-011LinkTranslational Neural Devices (UG3/UH3 - Clinical Trial Required)UG3/UH3NINDS10-22-2020

 

Simons Foundation Autism Research Initiative (SFARI)

SFARI Explorer Awards: This award program is designed to enhance our existing support of autism research by providing timely resources to enable focused experiments highly relevant to our mission. A deeper understanding of the mechanisms underlying autism spectrum disorders or potential therapeutic approaches will require investigation at multiple levels, including but not limited to studies focused on gene discovery, molecular mechanisms, circuits, anatomy, and cognition and behavior. We will consider proposals at all of these levels.

The maximum budget is $70,000, including indirect costs for one (1) year, non-renewable.

Explorer Awards are intended to provide resources to support exploratory experiments that will strengthen hypotheses and lead to the formulation of competitive applications for subsequent larger-scale funding by SFARI or other organizations. Innovative, high-risk/high-impact proposals are encouraged. We especially encourage applications from investigators who are new to the field of autism, but who have expertise that could be brought to bear on this complex disorder.

Applications are considered on a rolling basis, with a response time as early as 30 days.

National MS Society Pilot Grant Projects

The Society funds high-risk pilot grants to quickly test novel ideas. Funding is provided for one year to test innovative, cutting-edge ideas or untested methods, and to gather sufficient preliminary data to apply for longer-term funding. We welcome applications for studies related to multiple sclerosis that may serve to advance our mission of stopping MS progression, restoring function and improving quality of life, and preventing MS. The Society supports fundamental as well as applied studies, non-clinical or clinical in nature, including projects in patient management, care and rehabilitation.

Pilot research grants:Researchers who have completed their post-doctoral training are invited to apply. Individuals who are currently postdoctoral fellows or the equivalent, or who are graduate/medical students are not eligible for support under this program. In order to submit a proposal for research support, investigators must first register with our Apply Online site (https://nmss.fluxx.io/) and complete a pre-application. Staff will review the pre-application to determine whether the research plan is appropriate and relevant to our goals. NOTE: As of June 10, 2011, we will no longer accept pilot grant applications using the old application forms. All pilot applications must be submitted through the online application site (https://nmss.fluxx.io/).

Deadlines: New applications reviewed on a quarterly basis, with 2017 deadlines of January 4, April 5, July 12, October 4.
Download complete information on applying for pilot research grants (.pdf)

For more information, please contact: Elisabeth Mari, PhD
Elisabeth.Mari@nmss.org